Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
sST2 and beta-blocker outcomes in STEMI
ChiCTR-OPC-15006264Phase 4Not yet recruiting
- Sponsor
- Wuhan Asia Heart Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of carvedilol in myocardial infarction (MI), sponsored by Wuhan Asia Heart Hospital. Primary endpoints: all-cause mortality, cardiac death and 2 more. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
carvedilol
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-OPC-15006264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006264.